Related references
Note: Only part of the references are listed.In vivo toxicity evaluation of nanoemulsions for drug delivery
Mariana Appel Hort et al.
DRUG AND CHEMICAL TOXICOLOGY (2021)
Triamcinolone acetonide-loaded lipid nanocapsules for ophthalmic applications
M. L. Formica et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2020)
Environmental Predictors of Schistosomiasis Persistent Hotspots following Mass Treatment with Praziquantel
Joseph W. Walker et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2020)
Revolutionizing technologies of nanomicelles for combinatorial anticancer drug delivery
Min Jeong Jo et al.
ARCHIVES OF PHARMACAL RESEARCH (2020)
Searching for drugs for Chagas disease, leishmaniasis and schistosomiasis: a review
Soraya Silva Santos et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
Clinical and Preclinical Imaging of Hepatosplenic Schistosomiasis
Brice Masi et al.
TRENDS IN PARASITOLOGY (2020)
Schistosomiasis and hookworm infection in humans: Disease burden, pathobiology and anthelmintic vaccines
Anisuzzaman et al.
PARASITOLOGY INTERNATIONAL (2020)
Single oral fixed-dose praziquantel-miltefosine nanocombination for effective control of experimental schistosomiasis mansoni
Maha M. Eissa et al.
PARASITES & VECTORS (2020)
Nanocarrier-based drug combination therapy for glioblastoma
Mengnan Zhao et al.
THERANOSTICS (2020)
Size-Tailored Design of Highly Monodisperse Lipid Nanocapsules for Drug Delivery
Juan Aparicio-Blanco et al.
JOURNAL OF BIOMEDICAL NANOTECHNOLOGY (2019)
Drug delivery to tumours using a novel 5-FU derivative encapsulated into lipid nanocapsules
Giovanna Lollo et al.
JOURNAL OF DRUG TARGETING (2019)
Life cycle maintenance and drug-sensitivity assays for early drug discovery in Schistosoma mansoni
Flavio C. Lombardo et al.
NATURE PROTOCOLS (2019)
Advancing the Development of a Human Schistosomiasis Vaccine
Peter J. Hotez et al.
TRENDS IN PARASITOLOGY (2019)
Acting beyond 2020: better characterization of praziquantel and promising antischistosomal leads
Gordana Panic et al.
CURRENT OPINION IN PHARMACOLOGY (2018)
Praziquantel-lipid nanocapsules: an oral nanotherapeutic with potential Schistosoma mansoni tegumental targeting
Rokaya O. Amara et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2018)
Schistosome Egg Migration: Mechanisms, Pathogenesis and Host Immune Responses
Alice H. Costain et al.
FRONTIERS IN IMMUNOLOGY (2018)
Miltefosine lipid nanocapsules: Intersection of drug repurposing and nanotechnology for single dose oral treatment of pre-patent schistosomiasis mansoni
Riham M. El-Moslemany et al.
ACTA TROPICA (2016)
Population Pharmacokinetics and Pharmacodynamics of Praziquantel in Ugandan Children with Intestinal Schistosomiasis: Higher Dosages Are Required for Maximal Efficacy
Amaya L. Bustinduy et al.
MBIO (2016)
Miltefosine Lipid Nanocapsules for Single Dose Oral Treatment of Schistosomiasis Mansoni: A Preclinical Study
Maha M. Eissa et al.
PLOS ONE (2015)
Inhibition of Granulomatous Inflammation and Prophylactic Treatment of Schistosomiasis with a Combination of Edelfosine and Praziquantel
Edward Yepes et al.
PLOS NEGLECTED TROPICAL DISEASES (2015)
The little we know about the pharmacokinetics and pharmacodynamics of praziquantel (racemate and R-enantiomer)
Piero Olliaro et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2014)
Miltefosine: a review of its pharmacology and therapeutic efficacy in the treatment of leishmaniasis
Thomas P. C. Dorlo et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)
Miltefosine, a promising novel agent for schistosomiasis mansoni
Maha M. Eissa et al.
INTERNATIONAL JOURNAL FOR PARASITOLOGY (2011)
Bioactivity of miltefosine against aquatic stages of Schistosoma mansoni, Schistosoma haematobium and their snail hosts, supported by scanning electron microscopy
Maha M. Eissa et al.
PARASITES & VECTORS (2011)
New insight into praziquantel against various developmental stages of schistosomes
Wei Wu et al.
PARASITOLOGY RESEARCH (2011)
The gastrointestinal stability of lipid nanocapsules
E. Roger et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2009)
Lipid nanocapsules: A new platform for nanomedicine
N. T. Huynh et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2009)
Pharmacokinetics of miltefosine in Old World cutaneous leishmaniasis patients
Thomas P. C. Dorlo et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Development of miltefosine as an oral treatment for leishmaniasis
H. Sindermann et al.
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE (2006)
Share Paper
